Idelalisib-mediated PI3Kδ inhibition for optimized generation of CD19-specific chimeric antigen receptor T cells

被引：0
|
作者：
Stock, Sophia [1 ]
Schubert, Maria-Luisa [1 ]
Hoffmann, Jean-Marc [1 ]
Wang, Lei [1 ]
Gong, Wenjie [1 ]
Neuber, Brigitte [1 ]
Hueckelhoven, Angela [1 ]
Gern, Ulrike [1 ]
Schmitt, Anita [1 ]
Mueller-Tidow, Carsten [1 ,2 ]
Dreger, Peter [1 ,2 ]
Schmitt, Michael [1 ,2 ]
Sellner, Leopold [1 ,2 ]
机构：
[1] Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany
[2] German Canc Consortium DKTK, Heidelberg, Germany
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O141
引用
收藏
页码：119 / 120
页数：2
相关论文
共 50 条
  • [41] Cytokine release syndrome (CRS) and neurotoxicity (NT) after CD19-specific chimeric antigen receptor-(CAR-) modified T cells.
    Turtle, Cameron John
    Hay, Kevin Anthony
    Gust, Juliane
    Hanafi, Laila-Aicha
    Li, Daniel
    Liles, W. Conrad
    Wurfel, Mark
    Harju-Baker, Susanna
    Myerson, David
    Gonzalez-Cuyar, Luis
    Yeung, Cecilia C. S.
    Riddell, Stanley R.
    Maloney, David G.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Tumor Targeting Using CD19-Specific CAR (Chimeric Antigen Receptor) for B-Cell Lymphoma
    Tsukahara, Tomonori
    Ohmine, Ken
    Uchibori, Ryosuke
    Ido, Hiroyuki
    Urabe, Masashi
    Mizukami, Hiroaki
    Kume, Akihiro
    Nakamura, Masataka
    Mineno, Junichi
    Takesako, Kazutoh
    Riviere, Isabelle
    Sadelain, Michel
    Brentjens, Renier
    Ozawa, Keiya
    MOLECULAR THERAPY, 2013, 21 : S248 - S249
  • [43] Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib
    Turtle, Cameron J.
    Hay, Kevin A.
    Hanafi, Laila-Aicha
    Li, Daniel
    Cherian, Sindhu
    Chen, Xueyan
    Wood, Brent
    Lozanski, Arletta
    Byrd, John C.
    Heimfeld, Shelly
    Riddell, Stanley R.
    Maloney, David G.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (26) : 3010 - +
  • [44] Engineering of CD19-Specific Chimeric Antigen Receptor T Cells with the Integrin CD103 Results in Augmented Therapeutic Efficacy Against Human Lymphoma in a Preclinical Model
    Sun, Hongxing
    He, Shan
    Meng, Lijun
    Wang, Ying
    Zhang, Hanghang
    Liu, Yongnian
    Wang, Jian
    Tao, Min
    Barta, Stefan Klaus
    Al-Saleem, Essel D.
    Fung, Henry C.
    Issa, Jean-Pierre
    Zheng, Leizhen
    Zhang, Yi
    BLOOD, 2018, 132
  • [45] DURABLE REMISSIONS AFTER MONOTHERAPY WITH CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED T CELLS IN CHILDREN AND YOUNG ADULTS WITH RELAPSED/REFRACTORY ALL
    Maude, S.
    Teachey, D.
    Rheingold, S.
    Shaw, P.
    Aplenc, R.
    Barrett, D.
    Barker, C.
    Callahan, C.
    Frey, N.
    Nazimuddin, F.
    Lacey, S.
    Zheng, Z.
    Levine, B.
    Melenhorst, J.
    Motley, L.
    Porter, D.
    June, C.
    Grupp, S.
    HAEMATOLOGICA, 2016, 101 : 183 - 184
  • [46] A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR
    Torikai, Hiroki
    Reik, Andreas
    Liu, Pei-Qi
    Zhou, Yuanyue
    Zhang, Ling
    Maiti, Sourindra
    Huls, Helen
    Miller, Jeffrey C.
    Kebriaei, Partow
    Rabinovitch, Brian
    Lee, Dean A.
    Champlin, Richard E.
    Bonini, Chiara
    Naldini, Luigi
    Rebar, Edward J.
    Gregory, Philip D.
    Holmes, Michael C.
    Cooper, Laurence J. N.
    BLOOD, 2012, 119 (24) : 5697 - 5705
  • [47] Differential Role of Th1 and Th2 Cytokines in Autotoxicity Driven by CD19-Specific Second-Generation Chimeric Antigen Receptor T Cells in a Mouse Model
    Cheadle, Eleanor J.
    Sheard, Victoria
    Rothwell, Dominic G.
    Bridgeman, John S.
    Ashton, Garry
    Hanson, Vivien
    Mansoor, A. Wasat
    Hawkins, Robert E.
    Gilham, David E.
    JOURNAL OF IMMUNOLOGY, 2014, 192 (08): : 3654 - 3665
  • [48] Modification of hematopoietic stem cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy
    De Oliveira, Satiro N.
    Ryan, Christine
    Wherley, Jennifer
    Tu, Andy
    Elashoff, David
    Cooper, Laurence J. N.
    Hollis, Roger P.
    Kohn, Donald B.
    CANCER RESEARCH, 2014, 74 (20)
  • [49] Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells
    Terakura, Seitaro
    Yamamoto, Tori N.
    Gardner, Rebecca A.
    Turtle, Cameron J.
    Jensen, Michael C.
    Riddell, Stanley R.
    BLOOD, 2012, 119 (01) : 72 - 82
  • [50] Neurotoxicity Associated with CD19-specific Chimeric Antigen Receptor T cell Therapy for Adult Acute Lymphoblastic Leukemia (B-ALL)
    Santomasso, Bianca
    Park, Jae Hong
    Riviere, Isabelle
    Mead, Elena
    Li, Daniel
    Senechal, Brigitte
    Purdon, Terrence
    Halton, Elizabeth
    Diamonte, Claudia
    Sadelain, Michel
    Brenjens, Renier
    NEUROLOGY, 2018, 90
12345